NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $154,000 | -99.6% | 12 | -99.5% | 0.00% | -100.0% |
| Q1 2022 | $34,905,000 | -6.4% | 2,289 | +8.7% | 0.01% | +11.1% |
| Q4 2021 | $37,278,000 | +1806.8% | 2,105 | +2163.4% | 0.01% | – |
| Q3 2021 | $1,955,000 | -92.5% | 93 | -92.2% | 0.00% | -100.0% |
| Q2 2021 | $25,945,000 | -86.4% | 1,188 | -81.8% | 0.01% | -88.9% |
| Q1 2021 | $190,080,000 | +7.8% | 6,539 | +12.4% | 0.05% | +3.8% |
| Q4 2020 | $176,278,000 | – | 5,819 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |